To inform the 2013 revision of the WHO Guidelines on HIV treatment GNP+ and the HIV Alliance conducted community consultations.
Expanding antiretroviral therapy (ART) access is a cornerstone of reducing mortality and improving health outcomes among people living with HIV (PLHIV) in all settings. Given recent advances in scientific evidence on the use of antiretroviral drugs (ARVs) for HIV treatment, including their impact on health outcomes and HIV prevention, the World Health Organization (WHO) has reviewed and consolidated all ARV-related guidelines into a single compendium for publication in 2013.
The 2013 WHO Consolidated ARV Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2013 ARV Guidelines) focus on four areas:
(1) clinical guidelines for adults and adolescents;
(2) clinical guidelines for maternal and child health;
(3) operations and service delivery guidance (for the first time); and
(4) guidance for programme managers.
